Dr. Bell is bringing innovation and technology to IONIC. His team of PhD-level scientists and engineers are bridging the gap between biomedical science and the cannabis industry. His R&D laboratories are based at the Okinawa Institute of Science and Technology Graduate University. Thus making IONIC the first recreational cannabis company to work within a world-class university environment and have its R&D performed at the high-standards of Japanese excellence. Dr. Bell is an American, was formally trained as a neuroscientist at the University of London, and received his postdoctoral training in Japan. Prior to this, he trained at the following U.S. institutions: Icahn School of Medicine at Mount Sinai, Columbia University, and the University of Memphis. He brings over decade of leadership and project management to IONIC's R&D, and has published and presented his research around the world.
Current role